BIO-REFERENCE LABS INC-NEW-
BRLI
BRLI was delisted on the 19th of August, 2015.
162 hedge funds and large institutions have $743M invested in BIO-REFERENCE LABS INC-NEW- in 2014 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 55 reducing their positions, and 32 closing their positions.
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
294% more call options, than puts
Call options by funds: $21.7M | Put options by funds: $5.51M
16% more capital invested
Capital invested by funds: $642M → $743M (+$101M)
7% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 55
7% less funds holding
Funds holding: 175 → 162 (-13)
38% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 32
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$26.1M |
| 2 |
MRM
Michael R. Murphy
|
+$17M |
| 3 |
PIM
Perkins Investment Management
Chicago,
Illinois
|
+$12.5M |
| 4 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
+$11.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
-$10.6M |
| 2 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$7.97M |
| 3 |
ARC
Absolute Return Capital
Boston,
Massachusetts
|
-$7.32M |
| 4 |
CGI
CI Global Investments
Oakland,
California
|
-$7.02M |
| 5 |
QBFM
QS Batterymarch Financial Management
New York
|
-$5.76M |
BRLI Hedge Fund Activity: Q1 2014 in Review
162 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in BIO-REFERENCE LABS INC-NEW- (BRLI) for Q1 2014, worth a combined $743M — up 16% from $642M a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of BRLI and 20 opened new positions — a net loss of 12 holders — while 55 trimmed existing stakes and 59 added.
The largest buyer was Sarissa Capital Management, adding an estimated $26.1M. The largest seller was Schroder Investment Management Group, cutting an estimated $10.6M.
- 162 institutional investors held BIO-REFERENCE LABS INC-NEW- (BRLI) as of Q1 2014, down from 175 in Q4 2013.
- Funds reported $743M of BIO-REFERENCE LABS INC-NEW- stock for Q1 2014, up 16% quarter-over-quarter.
- 20 funds opened new BIO-REFERENCE LABS INC-NEW- positions in Q1 2014 and 32 closed out, a net change of -12 holders.
- The largest BIO-REFERENCE LABS INC-NEW- buyer in Q1 2014 was Sarissa Capital Management, an estimated $26.1M added.
- The largest BIO-REFERENCE LABS INC-NEW- seller in Q1 2014 was Schroder Investment Management Group, an estimated $10.6M sold.
Based on aggregated 13F filings for Q1 2014.